These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 32800470)
1. Ultrasound-Mediated Delivery of Chemotherapy into the Transgenic Adenocarcinoma of the Mouse Prostate Model. Fagerland ST; Berg S; Hill DK; Snipstad S; Sulheim E; Hyldbakk A; Kim J; Davies CL Ultrasound Med Biol; 2020 Nov; 46(11):3032-3045. PubMed ID: 32800470 [TBL] [Abstract][Full Text] [Related]
2. Sonopermeation Enhances Uptake and Therapeutic Effect of Free and Encapsulated Cabazitaxel. Snipstad S; Mørch Ý; Sulheim E; Åslund A; Pedersen A; Davies CL; Hansen R; Berg S Ultrasound Med Biol; 2021 May; 47(5):1319-1333. PubMed ID: 33549379 [TBL] [Abstract][Full Text] [Related]
3. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues. Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound Improves the Delivery and Therapeutic Effect of Nanoparticle-Stabilized Microbubbles in Breast Cancer Xenografts. Snipstad S; Berg S; Mørch Ý; Bjørkøy A; Sulheim E; Hansen R; Grimstad I; van Wamel A; Maaland AF; Torp SH; Davies CL Ultrasound Med Biol; 2017 Nov; 43(11):2651-2669. PubMed ID: 28781149 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Combined Ultrasound-and-Microbubbles-Mediated Diclofenac Gel Delivery to Enhance Transdermal Permeation in Adjuvant-Induced Rheumatoid Arthritis in the Rat. Liao AH; Chung HY; Chen WS; Yeh MK Ultrasound Med Biol; 2016 Aug; 42(8):1976-85. PubMed ID: 27181685 [TBL] [Abstract][Full Text] [Related]
6. Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model. Venier NA; Yamamoto T; Sugar LM; Adomat H; Fleshner NE; Klotz LH; Venkateswaran V Prostate; 2015 Sep; 75(12):1300-11. PubMed ID: 26047020 [TBL] [Abstract][Full Text] [Related]
7. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation. Morales PR; Dillehay DL; Moody SJ; Pallas DC; Pruett S; Allgood JC; Symolon H; Merrill AH Drug Chem Toxicol; 2007; 30(3):197-216. PubMed ID: 17613006 [TBL] [Abstract][Full Text] [Related]
8. Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest. Cho HJ; Lim DY; Kwon GT; Kim JH; Huang Z; Song H; Oh YS; Kang YH; Lee KW; Dong Z; Park JH Int J Mol Sci; 2016 Feb; 17(2):264. PubMed ID: 26907265 [TBL] [Abstract][Full Text] [Related]
9. Ultrasound and magnetic resonance imaging for group stratification and treatment monitoring in the transgenic adenocarcinoma of the mouse prostate model. Fagerland ST; Hill DK; van Wamel A; de Lange Davies C; Kim J Prostate; 2020 Feb; 80(2):186-197. PubMed ID: 31763715 [TBL] [Abstract][Full Text] [Related]
10. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells. Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156 [TBL] [Abstract][Full Text] [Related]
11. A TRAMP-derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti-tumor treatments. Lardizabal J; Ding J; Delwar Z; Rennie PS; Jia W Prostate; 2018 May; 78(6):457-468. PubMed ID: 29450905 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer. Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393 [TBL] [Abstract][Full Text] [Related]
13. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model. Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy. Wikström P; Lindahl C; Bergh A Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Rapoport N; Gao Z; Kennedy A J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles. Eggen S; Fagerland SM; Mørch Ý; Hansen R; Søvik K; Berg S; Furu H; Bøhn AD; Lilledahl MB; Angelsen A; Angelsen B; de Lange Davies C J Control Release; 2014 Aug; 187():39-49. PubMed ID: 24852099 [TBL] [Abstract][Full Text] [Related]
18. Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. Sorace AG; Warram JM; Umphrey H; Hoyt K J Drug Target; 2012 Jan; 20(1):43-54. PubMed ID: 21981609 [TBL] [Abstract][Full Text] [Related]
19. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. El Touny LH; Banerjee PP Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512 [TBL] [Abstract][Full Text] [Related]
20. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model. Tepaamorndech S; Huang L; Kirschke CP Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]